NCT05148689View on ClinicalTrials.gov

A Study Comparing Oxymetazoline 1% Cream to RHOFADE

PHASE1CompletedINTERVENTIONAL
Enrollment

82

Participants

Timeline

Start Date

February 23, 2018

Primary Completion Date

March 21, 2019

Study Completion Date

May 31, 2019

Conditions
Bioequivalence
Interventions
DRUG

Oxymetazoline hydrochloride Cream, 1%

Cream

DRUG

Rhofade™ (oxymetazoline) cream, 1%

cream

DRUG

Placebo

cream

Trial Locations (1)

75234

WAYcro, Dallas

All Listed Sponsors
lead

Sun Pharmaceutical Industries, Inc.

INDUSTRY

NCT05148689 - A Study Comparing Oxymetazoline 1% Cream to RHOFADE | Biotech Hunter | Biotech Hunter